Clinical Trial Update: A Prospective, Single-arm, Open-label Clinical Trial to Evaluate the Efficacy and Safety of Ivarmacitinib in the Treatment of Palmoplantar Pustulosis [NA]

View source ↗

Summary

Prospective, single-arm, open-label study to evaluate the efficacy and safety of Ivarmacitinib in palmoplantar pustulosis. The trial is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Palmoplantar Pustulosis

Drugs mentioned

• Ivarmacitinib

Snippet

Sponsor: Xijing Hospital | Conditions: Palmoplantar Pustulosis (PPP) | NA | Status: RECRUITING